Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 152.54 % in the past year, substantial increase in net sales/revenue by 59.79 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 81.03 %. Marginal increase in other income during this quarter, up by 45.83%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Coral Laboratories Ltd.. Profit dropped by -748.77 % Year to Year, Coral Laboratories Ltd.’s profitability increased by 168.41 % in this quarter.
- EPS over the Year and quarter: EPS declined by -748.00 % Year to Year. EPS increased by 168.21 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 11.438 Cr | Rs. 18.078 Cr | Rs. 28.886 Cr | + 59.79 % | + 152.54 % |
| Expenses | Rs. 13.52 Cr | Rs. 15.98 Cr | Rs. 22.64 Cr | + 41.68 % | + 67.46 % |
| Operating Profit | Rs. -2.08 Cr | Rs. 2.1 Cr | Rs. 6.25 Cr | + 197.62 % | + 400.48 % |
| OPM % | -18.18 % | 11.62 % | 21.64 % | + 10.02 % | + 39.82 % |
| Other Income | Rs. 1.16 Cr | Rs. 1.44 Cr | Rs. 2.1 Cr | + 45.83 % | + 81.03 % |
| Interest | Rs. 0.02 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0.68 Cr | Rs. 0.49 Cr | Rs. 0.5 Cr | + 2.04 % | -26.47 % |
| Profit before tax | Rs. -1.62 Cr | Rs. 3.05 Cr | Rs. 7.85 Cr | + 157.38 % | + 584.57 % |
| Tax % | -44.97 % | 27.55 % | 25.28 % | -2.27 % | + 70.25 % |
| Net Profit | Rs. -0.89 Cr | Rs. 2.16 Cr | Rs. 5.79 Cr | + 168.06 % | + 750.56 % |
| EPS in Rs | Rs. -2.5 | Rs. 6.04 | Rs. 16.2 | + 168.21 % | + 748 % |
Today, we’re looking at Coral Laboratories Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 152.54 %. However, it did see a marginal increase of 59.79 % from the previous quarter. Expenses ticked up slightly by 41.68 % quarter-on-quarter, aligning with the annual rise of 67.46 %. Operating profit, while up 400.48 % compared to last year, faced a quarter-on-quarter increase of 197.62 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 39.82 %, but an expansion of 10.02 % sequentially. Other income rose by 45.83 % compared to the last quarter, despite an annual growth of 81.03 %. Depreciation costs climbed by 2.04 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -26.47 %. Profit before tax grew annually by 584.57 % but saw an increase from the preceding quarter by 157.38 %.
Tax expenses as a percentage of profits increased slightly by 70.25 % compared to last year, with a more notable quarter-on-quarter decrease of -2.27 %. Net profit rose by 750.56 % year-on-year but experienced a 168.06 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 748 % but a quarterly rise of 168.21 %. In summary, Coral Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 11.438 Cr | Rs. 18.078 Cr | Rs. 28.886 Cr | + 59.79 % | + 152.54 % |
| Expenses | Rs. 13.52 Cr | Rs. 15.98 Cr | Rs. 22.64 Cr | + 41.68 % | + 67.46 % |
| Operating Profit | Rs. -2.08 Cr | Rs. 2.1 Cr | Rs. 6.25 Cr | + 197.62 % | + 400.48 % |
| Net Profit | Rs. -0.89 Cr | Rs. 2.16 Cr | Rs. 5.79 Cr | + 168.06 % | + 750.56 % |
| EPS in Rs | Rs. -2.5 | Rs. 6.04 | Rs. 16.2 | + 168.21 % | + 748 % |
In reviewing Coral Laboratories Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 152.54 % year-on-year growth, however, there was a minor increase of 59.79 % from the previous quarter. Expenses rose by 67.46 % compared to the previous year, with a 41.68 % increase quarter-on-quarter. Operating Profit surged by 400.48 % annually, and saw a 197.62 % increase from the last quarter.
Net Profit showed yearly increase of 750.56 %, and experienced a 168.06 % increase from the previous quarter. Earnings Per Share (EPS) rose by 748 % annually, however rose by 168.21 % compared to the last quarter. In essence, while Coral Laboratories Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
